2009 Press Releases
December 30
QLT Acquires Early-Stage Ophthalmic Asset for US$7.5 Million
PDF version
December 22
QLT Inc. Establishes Sales Force in the United States
December 15
QLT Initiates Phase Ib Study of QLT091001 in Leber Congenital Amaurosis
December 09
6-Month Results From EVEREST Study Evaluating Visudyne® Therapy in Patients with Polypoidal Choroidal Vasculopathy
November 25
QLT Announces MGH Litigation Settlement
October 28
QLT Announces Toronto Stock Exchange Approval of Share Repurchase Program
October 27
QLT Announces Share Repurchase Program
QLT Announces Third Quarter Results for 2009
October 19
QLT Restructures Visudyne® Agreement
October 01
QLT Announces Sale of QLT USA, Inc. For Up to US$230 Million
September 08
QLT Announces Receipt of a CDN$45.3 Million Tax Refund
July 28
QLT Announces Second Quarter Results for 2009
QLT Announces Interim Data From a Phase II Clinical Trial and a Device Study for the Punctal Plug Drug Delivery System
June 15
QLT Announces 12-Month Results From Novartis Sponsored MONT BLANC Study Evaluating Standard-Fluence Visudyne® Combination Therapy
June 02
QLT Announces Positive Results From the Evaluation of Visudyne® Combination Therapy
May 21
QLT Announces Court Response to Motion to Dismiss and Removal of Case to Federal Court
April 28
QLT Announces First Quarter Results for 2009
March 26
QLT Names Kathryn Falberg to the Board of Directors
March 12
QLT Announces Completion of Phase Ib Safety Trial of Its Synthetic Retinoid Product
February 24
QLT Petition for Rehearing of Massachusetts Eye and Ear Infirmary Litigation is Denied
February 19
QLT Announces Fourth Quarter and Year End 2008 Results
February 12
QLT Announces That It is Named as a Defendant in an Action
January 30
QLT Announces Final Results of Tender Offer
January 27
QLT Announces Preliminary Results of Tender Offer
January 15
QLT Announces New Expiration Date of Dutch Tender
January 12
QLT Announces Appeal Court Decision on Massachusetts Eye and Ear Infirmary Litigation
QLT Announces Visudyne® Sales for Fourth Quarter and Fiscal Year 2008
